No abstract available
MeSH terms
-
Animals
-
Autistic Disorder / drug therapy
-
Autistic Disorder / genetics*
-
Drosophila
-
Fragile X Mental Retardation Protein / genetics
-
Fragile X Syndrome / drug therapy
-
Fragile X Syndrome / genetics
-
Glutamic Acid / drug effects
-
Humans
-
Immunosuppressive Agents / therapeutic use
-
Methyl-CpG-Binding Protein 2 / genetics
-
Mice
-
Protein Kinases / drug effects
-
Protein Kinases / genetics
-
Rett Syndrome / drug therapy
-
Rett Syndrome / genetics
-
Sirolimus / therapeutic use
-
TOR Serine-Threonine Kinases
-
Tuberous Sclerosis / drug therapy
-
Tuberous Sclerosis / genetics
-
Tuberous Sclerosis Complex 1 Protein
-
Tuberous Sclerosis Complex 2 Protein
-
Tumor Suppressor Proteins / genetics
Substances
-
FMR1 protein, human
-
Immunosuppressive Agents
-
Methyl-CpG-Binding Protein 2
-
Tuberous Sclerosis Complex 1 Protein
-
Tuberous Sclerosis Complex 2 Protein
-
Tumor Suppressor Proteins
-
Fragile X Mental Retardation Protein
-
Glutamic Acid
-
Protein Kinases
-
MTOR protein, human
-
mTOR protein, mouse
-
TOR Serine-Threonine Kinases
-
Sirolimus